Skip to content

Clinical trials

Hepatitis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Country / region: United States Clear all

136 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20017
20021
200310
20045
20054
20066
20077
20084
20095
20103
201110
201211
201311
20149
20152
20162
20172
20182
20194
20202
20217
20225
20231
20241
20252
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed105
Terminated12
Unknown status8
Recruiting6
Withdrawn2
Suspended1
Not yet recruiting1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences19
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)11
National Institute of Allergy and Infectious Diseases (NIAID)8
Dynavax Technologies Corporation6
National Heart, Lung, and Blood Institute (NHLBI)4
Centers for Disease Control and Prevention3
GlaxoSmithKline3
University of North Carolina, Chapel Hill3
Vital Therapies, Inc.3
GlobeImmune2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis136
Hepatitis C43
Hepatitis B25
Liver Diseases25
Hepatitis C, Chronic19
Fibrosis14
Hepatitis B, Chronic14
Hepatitis, Chronic14
Virus Diseases12
HIV Infections11

Trials

Showing 1 to 25 of 136. Each trial links to its page on Pharma Observatory.

36 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.